The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung

Experimental Lung Research

Volumn 34, Issue 4, 2008, Pages 155-182

  Ormerod, Angela K ^a   Xing, Zhenlan ^a,b   Pedigo, Nancy G ^a   Mishra, Anjali ^a,c   Kaetzel, David M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PATENT EXAMINATION COOPERATION CENTER OF THE PATENT OFFICE   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Alveolarization; Calcitriol; Growth factor; Lung development; Retinoic acid

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; COLLAGEN; DEXAMETHASONE; ELASTIN; MC1288; RETINOIC ACID; SEOCALCITOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; FETUS LUNG MATURATION; FIBROBLAST; LUNG ALVEOLUS; MITOGENESIS; MORPHOGENESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; VITAMIN D RESPONSIVE ELEMENT;

ANIMALS; ANIMALS, NEWBORN; CALCITRIOL; CELL GROWTH PROCESSES; CELLS, CULTURED; COLLAGEN; DRUG SYNERGISM; ELASTIN; FACTOR VIII; FIBROBLASTS; LUNG; MITOGENS; PLATELET-DERIVED GROWTH FACTOR; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIMENTIN; VITAMIN D RESPONSE ELEMENT;

EID: 42449158574     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140801929325     Document Type: Article

References (72)

1. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P: Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest. 1985;76:1297-1305.
2. Tschanz SA, Damke BM, Burri PH: Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonate. 1995;68:229-245.
3. Grier DG, Halliday HL: Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin Neonatol. 2003;8:83-91.
4. Massaro GD, Massaro D: Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol. 1996;270:L305-L310.
5. Veness-Meehan KA, Bottone FG Jr, Stiles AD: Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res. 2000;48:434-444.
6. Massaro GD, Massaro D: Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997;3:675-677.
7. Srinivasan G, Bruce EN, Houtz PK, Bruce MC: Dexamethasone-induced changes in lung function are not prevented by concomitant treatment with retinoic acid. Am J Physiol Lung Cell Mol Physiol. 2002;283:L275-L287.
8. Collins MD, Mao GE: Teratology of retinoids. Annu Rev Pharmacol Toxicol. 1999;39:399-430.
9. DeLuca HF, Zierold C: Mechanisms and functions of vitamin D. Nutr Rev. 1998;56:S4-S10.
10. Glasgow JFT, Thomas PS: Rachitic respiratory distress in small preterm infants. Arch Dis Child. 1987;52:268-273.
11. Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H: Lung mechanics in rachitic rats. Am Rev Respir Dis. 1984;130:1108-1110.
12. Edelson JD, Chan S, Jassal D, Post M, Tanswell AK: Vitamin D stimulates DNA synthesis in alveolar type-II cells. Biochim Biophys Acta Mol Cell Res. 1994;1221:159-166.
13. Liebeskind A, Srinivasan S, Kaetzel DM, Bruce M: Retinoic acid stimulates immature lung fibroblast growth via a PDGF-mediated autocrine mechanism. Am J Physiol Lung Cell Mol Physiol. 2000;279:L81-L90.
14. Nguyen TM, Guillozo H, Marin L, Tordet C, Koite S, Garabedian M: Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am J Physiol. 1996;271:L392-L399.
15. Reichel H, Bishop JE, Koeffler HP, Norman AW: Evidence for 1,25-dihydroxyvitamin D3 production by cultured porcine alveolar macrophages. Mol Cell Endocrinol. 1991;75:163-167.
16. Mawer EB, Hayes ME, Heys SE, Davies M, White A, Stewart MF, Smith GN: Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small lung cancer cell line. J Clin Endocrinol Metab. 1994;79:554-560.
17. Boström H, Willetts K, Pekny M, Levéen P, Lindahl P, Hedstrand H, Pekna M, Hellström M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Törnell J, Heath JK, Betsholtz C: PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863-873.
18. Prodhan P, Kinane TB: Developmental paradigms in terminal lung development. BioEssays. 2002;24:1052-1059.
19. Pedigo N, Zhang H, Koszewski NJ, Kaetzel DM: A 5′-distal element mediates vitamin Dinducibility of PDGF-A gene transcription. Growth Factors. 2003;21:151-160.
20. Pedigo NG, Zhang HX, Mishra A, McCorkle JR, Ormerod AK, Kaetzel DM: Retinoic acid inducibility of the human PDGF-A gene is mediated by 5′-distal DNA motifs that overlap with basal enhancer and vitamin D response elements. Gene Expression 2007;14:1-12.
21. Al Jumaily W, Bruce MC: The postnatal age of rat lung fibroblasts influences G1/S phase transition in vitro. In Vitro Cell Dev Biol Anim. 1999;35:410-416.
22. Maul RS, Zhang HX, Reid JD, Pedigo NG, Kaetzel DM: Identification of a cell type-specific enhancer in the distal 5′-region of the platelet-derived growth factor A-chain gene. J Biol Chem. 1998;273:33239-33246.
23. Graham FL, Van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456-467.
24. 161) is required for receptor binding and mitogenic activity of the PDGF-AA homodimer. J Biol Chem. 1993;268:10482-10489.
25. Ucker DS, Ashwell JD, Nickas G: Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol. 1989;143:3461-3469.
26. Scherle W: Simple method for volumetry of organs in quantitative stereology. Mikroskopie. 1970;26:57-60.
27. Weibel ER: Morphometry of the Human Lung. Berlin: Springer-Verlag; 1963.
28. Littell RC, Milliken GA, Stroup WW, Wolfinger RD: SAS System for mixed models. Cary NC: SAS; 1996.
29. Bouillon R, Okamura WH, Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995;16:200-257.
30. Hansen CM, Maenpaa PH: EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem Pharmacol. 1997;54:1173-1179.
31. Hansen CM, Hamberg KJ, Binderup E, Binderup L: Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des. 2000;6:803-828.
32. Pakkala I, Savli H, Knuutila S, Binderup L, Pakkala S: CB1093, a novel vitamin D analog; effects on differentiation and clonal growth on HL-60 and de novo leukemia cells. Leuk Res. 1997;21:321-326.
33. Carlberg C: Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem. 2003;88:274-281.
34. de Vos S, Holden S, Heber D, Elstner E, Binderup L, Uskokovic M, Rude B, Chen DL, Le J, Cho SK, Koeffler HP: Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines. Prostate. 1997;31:77-83.
35. Kaetzel DM: Transcription of the platelet-derived growth factor A-chain gene. Cytokine Growth Factor Rev. 2003;14:427-446.
36. Schrader M, Kahlen JP, Carlberg C: Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. Biochem Biophys Res Commun. 1997;230:646-651.
37. Tovar Sepulveda VA, Weigel NL, Falzon M: Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Steroids. 2005;204:51-64.
38. Kornfehl J, Formanek M, Temmel A, Knerer B, Willheim M: Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol. 1996;253:341-344.
39. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L: Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev. 1999;8:241-248.
40. Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M, Koeffler HP: Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res. 1999;19:519-524.
41. Massaro GD, Massaro D: Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol. 2000;278:L955-L960.
42. Escolar JD, Tejero C, Escolar MA, Montalvo F, Garisa R: Architecture, elastic fiber, and collagen in the distal air portion of the lung of the 18-month-old rat. Anat Rec. 1997;248:63-69.
43. Escolar JD, Tejero C, Escolar MA, Montalvo F, Garisa R: Methodological contributions for the morphometric study of the lung: approximation to the ideal sample size and quantification of collagen fiber. Anat Rec. 1997;247:501-511.
44. Bachofen H, Schurch S, Urbinelli M, Weibel ER: Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol. 1987;62:1878-1887.
45. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C: Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res. 2005;57:38R-46R.
46. Mandeville I, Aubin J, LeBlanc M, Lalancette-Hebert M, Jenelle MF, Trembly GM, Jeannotte L: Impact of the loss of Hoxa5 function on lung alveogenesis. Am J Pathol 2006;169:1312-1327.
47. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinnovitch M, Shinewell ES, Dixit A: Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol 2007;294:L3-L14.
48. Weissen-Plenz G, Eschert H, Volker W, Sindermann JR, Beissert S, Robenek H, Scheld HH, Breithardt G: Granulocyte macrophage colony-stimulating factor deficiency affects vascular elastin production and integrity of elastic lamellae. 2007;45:103-110.
49. Mariani TJ, Reed JJ, Shapiro SD: Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol. 2002;26:541-548.
50. Thibeault DW, Mabry SM, Ekekezie II, Zhang X, Truog WE: Collagen scaffolding during development and its deformation with chronic lung disease. Pediatrics. 2003;111:766-776.
51. Randell SH, Mercer RR, Young SL: Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. Am J Anat. 1989;186:55-68.
52. Meyrick B, Reid L: Pulmonary arterial and alveolar development in normal postnatal rat lung. Am Rev Respir Dis. 1982;125:468-473.
53. Swee MH, Parks WC, Pierce RA: Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J Biol Chem. 1995;270:14899-14906.
54. Nakamura T, Liu M, Mourgeon E, Slutsky A, Post M: Mechanical strain and dexamethasone selectively increase surfactant protein C and tropoelastin gene expression. Am J Physiol Lung Cell Mol Physiol. 2000;278:L974-L980.
55. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Tornell J, Heath JK, Betsholtz C: PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863-873.
56. Mehrotra M, Krane SM, Walters K, Pilbeam C: Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem. 2004;93:741-752.
57. Norman AW, Manchand PS, Uskokovic MR, Okamura WH, Takeuchi JA, Bishop JE, Hisatake JI, Koeffler HP, Peleg S: Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. J Med Chem. 2000;43:2719-2730.
58. Ryhanen S, Jaaskelainen T, Saarela JT, Maenpaa PH: Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093). J Cell Biochem. 1998;70:414-424.
59. Oades GM, Dredge K, Kirby RS, Colston KW: Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int. 2002;90:607-616.
60. Yang W, Freedman LP: 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor. J Biol Chem. 1999;274:16838-16845.
61. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C: Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem. 1997;66:552-562.
62. Danielsson C, Fehsel K, Polly P, Carlberg C: Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues. Cell Death Differ. 1998;5:946-952.
63. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH: Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst. 2001;93:745-753.
64. Nayeri S, Danielsson C, Kahlen JP, Schrader M, Mathiasen IS, Binderup L, Carlberg C: The antiproliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene. 1995;11:1853-1858.
65. Quack M, Carlberg C: Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Mol Pharmacol. 1999;55:1077-1087.
66. Vanhooke JL, Benning MM, Bauer CB, Pike JW, DeLuca HF: Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry. 2004;43:4101-4110.
67. Tocchini-Valentini G, Rochel N, Wurtz JM, Moras D: Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification. J Med Chem. 2004;47:1956-1961.
68. Dilworth FJ, Calverley MJ, Makin HL, Jones G: Increased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding. Biochem Pharmacol. 1994;47:987-993.
69. Garber SJ, Zhang H, Foley JP, Zhao H, Butler SJ, Godinez RI, Godinez MH, Gow AJ, Savani RC: Hormonal regulation of alveolarization: structure-function correlation. Respir Res. 2006;7:47-59.
70. Veness-Meehan KA, Pierce RA, Moats-Staats BM, Stiles AD: Retinoic acid attenuates O2-induced inhibition of lung septation. Am J Physiol Lung Cell Mol Physiol. 2002;283:L971-L980.
71. Willet KE, Jobe AH, Ikegami M, Newnham J, Sly PD: Antenatal retinoic acid does not alter alveolization or postnatal lung function in preterm sheep. Eur Respir J. 2000;16:101-107.
72. Archavachotikul K, Ciccone TJ, Chinoy MR, Nielsen HC, Volpe MV: Thyroid hormone affects embryonic mouse lung branching morphogenesis and cellular differentiation. Am J Physiol Lung Cell Mol Physiol. 2002;282:L359-L369.